Author details

Full Name

Andrew J Elia

Affiliation

University Health Network, Princess Margaret Cancer Centre

ORCID

Career Start Year

1995

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36736318	IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.	Cancer Cell	2023
37640929	Tumor-specific cholinergic CD4<sup>+</sup> T lymphocytes guide immunosurveillance of hepatocellular carcinoma.	Nat Cancer	2023
35167826	Cisplatin toxicity in the developing brain displays an absolute requirement for caspase-3.	Exp Neurol	2022
36108220	Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer.	Cancer Discov	2022
32844322	Necroptotic-Apoptotic Regulation in an Endothelin-1 Model of Cerebral Ischemia.	Cell Mol Neurobiol	2021
34518219	Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer.	Proc Natl Acad Sci U S A	2021
33382742	Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity.	PLoS One	2020
30733420	Choline acetyltransferase-expressing T cells are required to control chronic viral infection.	Science	2019
31892360	High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.	J Immunother Cancer	2019
31741762	Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer.	Oncoimmunology	2019
31073782	Endothelin-1-mediated cerebral ischemia in mice: early cellular events and the role of caspase-3.	Apoptosis	2019
29378962	Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.	Proc Natl Acad Sci U S A	2018
28137882	E3 ubiquitin ligase Mule targets Î²-catenin under conditions of hyperactive Wnt signaling.	Proc Natl Acad Sci U S A	2017
27058317	Metabolic reprogramming during neuronal differentiation.	Cell Death Differ	2016
27424808	Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.	Cancer Cell	2016
27184401	Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal Degradation.	Cell Stem Cell	2016
26915295	The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair.	Cell Death Differ	2016
25620030	Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.	Cancer Cell	2015
25882048	Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.	Cell Death Differ	2015
23435421	PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.	Oncogene	2014
24747746	Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex.	Nat Med	2014
24656129	Largen: a molecular regulator of mammalian cell size control.	Mol Cell	2014
24449892	TAp73 is required for spermatogenesis and the maintenance of male fertility.	Proc Natl Acad Sci U S A	2014
23708664	Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.	Oncogene	2014
22614012	Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression.	Oncogene	2013
23857982	BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.	J Exp Med	2013
23946427	Retinoblastoma tumor suppressor protein in pancreatic progenitors controls Î±- and Î²-cell fate.	Proc Natl Acad Sci U S A	2013
23699408	Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.	Genes Dev	2013
23787995	Functional significance of glutamate-cysteine ligase modifier for erythrocyte survival in vitro and in vivo.	Cell Death Differ	2013
23412344	Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.	Cell Death Differ	2013
22213803	The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.	J Exp Med	2012
23213242	2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.	Proc Natl Acad Sci U S A	2012
22925884	D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function.	Genes Dev	2012
21636789	Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.	Proc Natl Acad Sci U S A	2011
21597464	Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death.	Cell Death Differ	2011
21576264	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes Dev	2011
20133630	Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.	Proc Natl Acad Sci U S A	2010
20543135	Identification of BERP (brain-expressed RING finger protein) as a p53 target gene that modulates seizure susceptibility through interacting with GABA(A) receptors.	Proc Natl Acad Sci U S A	2010
20566848	Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay.	Proc Natl Acad Sci U S A	2010
20679220	Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.	Proc Natl Acad Sci U S A	2010
18550520	Inhibition of apoptosome activation protects injured motor neurons from cell death.	J Biol Chem	2008
18835195	Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis.	Immunity	2008
16446425	Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.	Proc Natl Acad Sci U S A	2006
15907471	Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis.	Cell	2005
15026330	Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.	Cancer Res	2004
15343267	Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.	EMBO J	2004
15492213	grb2 heterozygosity rescues embryonic lethality but not tumorigenesis in pten+/- mice.	Proc Natl Acad Sci U S A	2004
14757745	Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death.	J Exp Med	2004
12925852	The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.	Nat Immunol	2003
11937492	Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells.	Genes Dev	2002

1 - 50 of 81

Sophie Leboucher

Institut Curie, Universite PSL, CNRS UMR8

Career Start Year 2015

Number of shared co-authors 1

Wendy Dubois

Center for Cancer Research, National Cancer Institute

Career Start Year 2000

Number of shared co-authors 0

Bingbing Yuan

Whitehead Institute for Biomedical Research

Career Start Year 2000

Number of shared co-authors 1

An-Chi Tien

Barrow Neurological Institute, St. Joseph's Hospital & Medical Center

Career Start Year 1999

Number of shared co-authors 0

Yan Liu

Chengdu Medical College

Career Start Year 1999

Number of shared co-authors 0

Jianjun Shen

The University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 0

Youngsoo Lee

University of Wisconsin-Madison School of Medicine and Public Health

Career Start Year 1998

Number of shared co-authors 0

Yaoqi Alan Wang

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 0

Kevin S Smith

Stanford University

Career Start Year 1997

Number of shared co-authors 1

Dongquan Chen

University of Alabama at Birmingham

Career Start Year 1997

Number of shared co-authors 0

Jose Antonio Rodriguez

University of the Basque Country (UPV/EHU)

Career Start Year 1995

Number of shared co-authors 0

Brian James

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 1995

Number of shared co-authors 1

Tamilla Nechiporuk

Knight Cancer Institute, Oregon Health and Science University

Career Start Year 1994

Number of shared co-authors 1

Ping Wei

Fudan University Shanghai Cancer Center

Career Start Year 1993

Number of shared co-authors 0

Ute Fischer

Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf

Career Start Year 1992

Number of shared co-authors 0

Jan Willem Voncken

Maastricht University

Career Start Year 1992

Number of shared co-authors 2

Eric J Huang

University of California san francisco

Career Start Year 1990

Number of shared co-authors 0

Dirk Geerts

Amsterdam University Medical Center

Career Start Year 1989

Number of shared co-authors 0

Kaoru Saijo

Helen Wills Neuroscience Institute, University of California berkeley

Career Start Year 1988

Number of shared co-authors 0

Haruhiko Koseki

RIKEN Research Center for Allergy and Immunology

Career Start Year 1986

Number of shared co-authors 2

Tarik M??r??y

Institut de recherches cliniques de Montreal

Career Start Year 1985

Number of shared co-authors 0

Daniel C Link

Washington University School of Medicine

Career Start Year 1982

Number of shared co-authors 0

Tom Curran

Medical University of South Carolina

Career Start Year 1982

Number of shared co-authors 1

Carlos L??pez-Ot??n

Instituto Universitario de Oncologia, Universidad de Oviedo

Career Start Year 1982

Number of shared co-authors 4

Ze'ev Ronai

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 1981

Number of shared co-authors 1

Lionel Feigenbaum

Science Applications International Corporation/Frederick

Career Start Year 1981

Number of shared co-authors 0

David J Adams

Wellcome Sanger Institute

Career Start Year 1980

Number of shared co-authors 8

Ann M Flenniken

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital

Career Start Year 1980

Number of shared co-authors 5

Bruce J Aronow

Cincinnati Children's Hospital Medical Center

Career Start Year 1975

Number of shared co-authors 2

Mario R Capecchi

University of Utah School of Medicine

Career Start Year 1965

Number of shared co-authors 1

row(s) 1 - 30 of 30

Tak W Mak

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 65

Andrew Wakeham

Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network

Co-authored papers 39

Razqallah Hakem

Princess Margaret Cancer Centre, University Health Network, University of Toronto

Co-authored papers 9

Chiara Gorrini

Division of Clinical Studies, The Institute of Cancer Research

Co-authored papers 9

David W Cescon

Princess Margaret Cancer Centre

Co-authored papers 8

Thorsten Berger

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 8

Jacqueline M Mason

Campbell Family Institute for Breast Cancer Research, University Health Network

Co-authored papers 5

Ming-Sound Tsao

University Health Network, University of Toronto

Co-authored papers 5

Susan J Done

University Health Network

Co-authored papers 5

Anne Hakem

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 4

Hal K Berman

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 3

Yi Zheng

Children's Hospital Research Foundation

Co-authored papers 3

Tony Pawson

Co-authored papers 2

Rama Khokha

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 2

Evan F Lind

Oregon Health & Science University

Co-authored papers 2

Heiko Blaser

Princess Margaret Cancer Centre

Co-authored papers 2

Janet Rossant

The Hospital for Sick Children

Co-authored papers 2

Blaise A Clarke

University of Toronto.

Co-authored papers 2

Derek van der Kooy

University of Toronto

Co-authored papers 2

Patricia A Shaw

Princess Margaret Cancer Centre, University Avenue

Co-authored papers 2

Robert G Bristow

University of Toronto

Co-authored papers 2

Jeremy A Squire

University of Sao Paulo

Co-authored papers 2

Andrea Jurisicova

Lunenfeld-Tanenbaum Research Institute

Co-authored papers 2

Samah El Ghamrasni

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 2

Shelley L Berger

Penn Epigenetics Institute, Perelman School of Medicine

Co-authored papers 2

David M Sabatini

Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology

Co-authored papers 1

Ivan Topisirovic

McGill University

Co-authored papers 1

Syed Haider

Institute of Cancer Research

Co-authored papers 1

Dorit Donoviel

Translational Research Institute for Space Health

Co-authored papers 1

Colin McKerlie

The Hospital for Sick Children

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators